Nilsson Lena, Ahlbom Anders, Farahmand Bahman Y, Tomson Torbjōrn
Department of Neurological Rehabilitation, Stora Sköndal Hospital, Sköndal, Sweden.
Epilepsia. 2003 Apr;44(4):575-81. doi: 10.1046/j.1528-1157.2003.03302.x.
To investigate mortality and especially the incidence of sudden unexpected death in epilepsy (SUDEP) in a population-based cohort of epilepsy surgery patients.
All patients who underwent epilepsy surgery treatment between January 1990 and December 1998 (surgery patients) or whose presurgical evaluation started, although not leading to an operation, during the same period (nonsurgery patients) were identified through the Swedish National Epilepsy register. All subjects were followed up through the Cause of Death Register until December 1998. Standardized mortality ratios (SMRs) for all causes of death and incidence of SUDEP were calculated.
During the study period, 651 surgical operations were carried out on 596 patients (316 male). Of those, 14 patients died (six in SUDEP), rendering a total SMR of 4.9 [95% confidence interval (CI), 2.7-8.3]. SUDEP incidence was 2.4 per 1,000 person years. No major differences were found in SMRs or SUDEP rates between subgroups when stratifying for type of operation and for seizure outcome 2 years after surgery. SMR and SUDEP rates were higher in right-sided temporal lobe resections for gliosis than in left-sided, but the number of deaths was small. Among 212 nonsurgery patients, five died (four in SUDEP). The SMR for all causes was 7.9 (2.6-18.4), and SUDEP incidence, 6.3 per 1,000 person years.
In this large and strictly population-based cohort, SMR for all causes and SUDEP incidence among surgery patients were similar to those of other studies. No differences in overall mortality emerged by seizure outcome, but none of the SUDEP cases was seizure free at the time of death. Four of five deaths in the nonsurgery group occurred during the surgery evaluation period. Mortality appeared to be lower for surgery than for nonsurgery patients, and the interpretation of this finding is discussed.
在一个基于人群的癫痫手术患者队列中,调查死亡率,尤其是癫痫性猝死(SUDEP)的发生率。
通过瑞典国家癫痫登记处识别出1990年1月至1998年12月期间接受癫痫手术治疗的所有患者(手术患者),或同期开始进行术前评估但未进行手术的患者(非手术患者)。所有受试者通过死因登记处进行随访,直至1998年12月。计算所有死因的标准化死亡率(SMR)和SUDEP的发生率。
在研究期间,对596例患者(316例男性)进行了651次手术。其中,14例患者死亡(6例死于SUDEP),总SMR为4.9[95%置信区间(CI),2.7 - 8.3]。SUDEP发生率为每1000人年2.4例。在按手术类型和术后2年的癫痫发作结果分层时,各亚组之间的SMR或SUDEP率未发现重大差异。右侧颞叶胶质增生切除术的SMR和SUDEP率高于左侧,但死亡人数较少。在212例非手术患者中,5例死亡(4例死于SUDEP)。所有原因的SMR为7.9(2.6 - 18.4),SUDEP发生率为每1000人年6.3例。
在这个大型且严格基于人群的队列中,手术患者所有原因的SMR和SUDEP发生率与其他研究相似。癫痫发作结果未显示总体死亡率有差异,但所有SUDEP病例在死亡时均未无癫痫发作。非手术组的5例死亡中有4例发生在手术评估期间。手术患者的死亡率似乎低于非手术患者,并对这一发现进行了讨论。